Title | Type | SJR | H index | Total Docs. (2003) | Total Docs. (3years) | Total Refs. (2003) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2003) | %Female (2003) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Current Opinion in Molecular Therapeutics | journal | 1.024 Q1 | 67 | 101 | 252 | 4049 | 725 | 232 | 2.95 | 40.09 | 20.81 | |
52 | Journal of Psychopharmacology | journal | 1.017 Q1 | 135 | 74 | 186 | 2578 | 491 | 173 | 2.11 | 34.84 | 34.08 | |
53 | PharmacoEconomics | journal | 1.006 Q1 | 118 | 103 | 328 | 4348 | 869 | 317 | 2.53 | 42.21 | 33.75 | |
54 | Antiviral Research | journal | 0.995 Q1 | 151 | 95 | 230 | 4546 | 757 | 230 | 3.36 | 47.85 | 31.01 | |
55 | Naunyn-Schmiedeberg's Archives of Pharmacology | journal | 0.984 Q1 | 99 | 156 | 479 | 5878 | 1208 | 477 | 2.01 | 37.68 | 33.28 | |
56 | Drug Safety | journal | 0.981 Q1 | 140 | 82 | 257 | 5422 | 1071 | 252 | 3.67 | 66.12 | 32.71 | |
57 | Experimental and Clinical Psychopharmacology | journal | 0.973 Q1 | 101 | 34 | 177 | 1404 | 305 | 176 | 1.39 | 41.29 | 33.04 | |
58 | European Journal of Pharmacology | journal | 0.971 Q1 | 203 | 759 | 2506 | 31129 | 6504 | 2501 | 2.49 | 41.01 | 32.43 | |
59 | Expert Opinion on Investigational Drugs | journal | 0.971 Q1 | 117 | 153 | 769 | 13274 | 2287 | 745 | 2.99 | 86.76 | 22.01 | |
60 | European Neuropsychopharmacology | journal | 0.926 Q1 | 130 | 88 | 229 | 3082 | 561 | 224 | 2.36 | 35.02 | 29.86 | |
61 | Pharmacogenomics | journal | 0.921 Q1 | 100 | 95 | 159 | 3303 | 452 | 145 | 2.48 | 34.77 | 22.96 | |
62 | Anti-Cancer Drug Design | journal | 0.917 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
63 | Investigational New Drugs | journal | 0.907 Q1 | 97 | 46 | 130 | 1813 | 337 | 127 | 2.37 | 39.41 | 37.02 | |
64 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.906 Q1 | 108 | 41 | 57 | 4139 | 140 | 55 | 2.46 | 100.95 | 26.36 | |
65 | Steroids | journal | 0.906 Q1 | 114 | 134 | 351 | 5085 | 975 | 348 | 2.46 | 37.95 | 37.18 | |
66 | Receptors and Channels | journal | 0.887 Q1 | 44 | 40 | 71 | 2478 | 131 | 67 | 2.00 | 61.95 | 25.97 | |
67 | Cancer Chemotherapy and Pharmacology | journal | 0.881 Q1 | 122 | 146 | 482 | 4482 | 1184 | 480 | 2.29 | 30.70 | 28.83 | |
68 | Progress in Medicinal Chemistry | journal | 0.872 Q1 | 38 | 8 | 25 | 1155 | 61 | 16 | 2.42 | 144.38 | 0.00 | |
69 | Expert Opinion on Biological Therapy | journal | 0.869 Q1 | 102 | 116 | 176 | 9049 | 509 | 167 | 2.89 | 78.01 | 23.77 | |
70 | International Immunopharmacology | journal | 0.856 Q1 | 149 | 184 | 593 | 7210 | 1591 | 583 | 2.44 | 39.18 | 34.54 | |
71 | Planta Medica | journal | 0.853 Q1 | 135 | 272 | 738 | 4925 | 1310 | 735 | 1.63 | 18.11 | 35.40 | |
72 | Journal of Ethnopharmacology | journal | 0.840 Q1 | 231 | 257 | 668 | 6346 | 1187 | 662 | 1.54 | 24.69 | 35.93 | |
73 | British Journal of Clinical Pharmacology | journal | 0.819 Q1 | 167 | 205 | 577 | 5667 | 1504 | 511 | 2.62 | 27.64 | 26.92 | |
74 | Journal of Cardiovascular Pharmacology | journal | 0.812 Q1 | 109 | 280 | 865 | 8842 | 1764 | 856 | 2.10 | 31.58 | 22.17 | |
75 | Journal of Biomolecular Screening | journal | 0.799 Q2 | 86 | 68 | 147 | 1404 | 373 | 139 | 2.47 | 20.65 | 35.71 | |
76 | Chirality | journal | 0.784 Q2 | 83 | 135 | 357 | 3989 | 616 | 352 | 1.63 | 29.55 | 23.11 | |
77 | Antiviral Chemistry and Chemotherapy, Supplement | journal | 0.778 Q2 | 12 | 0 | 17 | 0 | 57 | 17 | 3.35 | 0.00 | 0.00 | |
78 | Bulletin of Mathematical Biology | journal | 0.771 Q2 | 97 | 52 | 144 | 1790 | 231 | 143 | 1.56 | 34.42 | 23.85 | |
79 | Clinical Neuropharmacology | journal | 0.755 Q2 | 85 | 66 | 185 | 1726 | 470 | 175 | 2.42 | 26.15 | 29.77 | |
80 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.734 Q2 | 68 | 95 | 189 | 2887 | 371 | 172 | 1.93 | 30.39 | 27.60 | |
81 | Chemical Biology and Drug Design | journal | 0.734 | 91 | 64 | 283 | 2109 | 484 | 278 | 1.66 | 32.95 | 35.71 | |
82 | Perspectives in Drug Discovery and Design | journal | 0.730 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
83 | Therapeutic Drug Monitoring | journal | 0.717 Q2 | 102 | 109 | 357 | 2652 | 923 | 343 | 2.63 | 24.33 | 30.69 | |
84 | Journal of Antibiotics | journal | 0.716 Q2 | 92 | 146 | 493 | 2236 | 637 | 395 | 1.13 | 15.32 | 25.99 | |
85 | Journal of Clinical Pharmacology | journal | 0.707 Q2 | 130 | 138 | 498 | 4346 | 1183 | 487 | 2.26 | 31.49 | 30.64 | |
86 | Clinical and Experimental Pharmacology and Physiology | journal | 0.705 Q2 | 115 | 153 | 581 | 5451 | 1112 | 578 | 1.86 | 35.63 | 35.25 | |
87 | Current Opinion in Drug Discovery and Development | journal | 0.700 Q2 | 85 | 94 | 252 | 4970 | 556 | 238 | 2.34 | 52.87 | 24.31 | |
88 | CNS and Neurological Disorders - Drug Targets | journal | 0.699 Q2 | 96 | 39 | 43 | 5178 | 82 | 43 | 1.91 | 132.77 | 38.61 | |
89 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 0.697 Q2 | 150 | 148 | 392 | 8355 | 778 | 388 | 2.13 | 56.45 | 35.62 | |
90 | Xenobiotica | journal | 0.689 Q2 | 89 | 92 | 238 | 2765 | 547 | 236 | 2.33 | 30.05 | 31.63 | |
91 | European Journal of Medicinal Chemistry | journal | 0.687 Q2 | 203 | 123 | 285 | 3662 | 600 | 281 | 1.89 | 29.77 | 35.62 | |
92 | Skin Pharmacology and Physiology | journal | 0.679 Q2 | 86 | 47 | 165 | 1229 | 305 | 163 | 1.90 | 26.15 | 35.25 | |
93 | Journal of Pharmacokinetics and Pharmacodynamics | journal | 0.674 Q2 | 70 | 21 | 54 | 473 | 80 | 51 | 1.48 | 22.52 | 23.08 | |
94 | Infectious Disorders - Drug Targets | journal | 0.668 Q2 | 61 | 33 | 57 | 3759 | 119 | 55 | 2.09 | 113.91 | 31.51 | |
95 | European Journal of Clinical Pharmacology | journal | 0.651 Q2 | 123 | 156 | 463 | 4240 | 1045 | 430 | 1.97 | 27.18 | 29.35 | |
96 | CNS Drug Reviews | journal | 0.648 Q2 | 64 | 22 | 72 | 1957 | 148 | 72 | 2.65 | 88.95 | 32.20 | |
97 | Biomedical Chromatography | journal | 0.647 Q2 | 71 | 79 | 257 | 1869 | 343 | 255 | 1.29 | 23.66 | 34.35 | |
98 | Anti-Cancer Drugs | journal | 0.642 Q2 | 102 | 131 | 391 | 4304 | 816 | 389 | 2.19 | 32.85 | 29.58 | |
99 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.636 Q2 | 57 | 45 | 120 | 1937 | 163 | 108 | 1.51 | 43.04 | 17.33 | |
100 | Journal of AOAC International | journal | 0.634 Q2 | 100 | 168 | 642 | 2909 | 825 | 640 | 1.18 | 17.32 | 40.21 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®